ASX and Australia’s peak biotechnology industry body, AusBiotech, have released
the world’s first Code of Best Practice for Reporting by Life Science Companies.

The Code is designed to bridge the “information gap” between the biotechnology industry and investors by
providing a disclosure framework that identifies the key drivers of value for Life Science companies and gives guidance to companies on the information investors need to make informed investment decisions.